Stimulation of toll-like receptor pathways by burn eschar tissue as a possible mechanism for hypertrophic scarring.
Abstract
Hypertrophic scars (HTS) are a common complication following burn injuries with prolonged inflammation. They do not respond well to current treatment options including mechanical, biomolecular and surgical therapies. Toll-like receptor (TLR) 2 and 4 respond to microbes and damaged endogenous ligands to trigger pro-inflammatory pathways, and they are expressed more in HTS fibroblasts compared to normal skin fibroblasts. TLR2 responds to microbial lipoteichoic acid (LTA) while TLR4 responds to microbial lipopolysaccharide (LPS) and endogenous ligands. We investigated the role of burn tissue and small leucine-rich proteoglycans (decorin and biglycan) in the stimulation of TLR2 and TLR4 pathways using cells stably transfected with TLR2 or TLR4 linked to a reporter system. Normal skin (n = 5) was collected post-abdominoplasty, and burn eschar samples (n = 18) were collected from 18 patients between 0 and 14 days post-burn. We found that burn tissue stimulates TLR2 activity significantly more than normal tissue and contains significantly higher levels of LTA. Burn tissue was a stronger stimulator of TLR4 than was normal skin. Burn tissue samples' stimulation of TLR4 and TLR2 correlated. The time post-burn (0-14 days) of wound tissue sampling correlated positively but moderately with TLR2 and TLR4 simulation. In comparison to the dose-dependent effects of natural decorin or biglycan on TLR4 activation, their denatured forms exhibited stronger or weaker stimulation, respectively. They were not potent stimulators of TLR2. TLR2 and TLR4 stimulation is not limited to bacteria in wounds and likely involves multiple endogenous damage-associated molecular patterns. Insight into mechanisms of HTS will facilitate the development of future targeted therapies to modify wound progression and provide benefits to patients suffering with HTS and other fibroproliferative disorders.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | abdominoplasty
|
복부성형술 | dict | 1 | |
| 해부 | eschar tissue
|
scispacy | 1 | ||
| 해부 | fibroblasts
|
scispacy | 1 | ||
| 해부 | skin fibroblasts
|
scispacy | 1 | ||
| 해부 | LTA
→ lipoteichoic acid
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 해부 | skin
|
scispacy | 1 | ||
| 합병증 | wound tissue
|
scispacy | 1 | ||
| 합병증 | wounds
|
scispacy | 1 | ||
| 합병증 | wound
|
scispacy | 1 | ||
| 약물 | lipoteichoic acid
|
C0065067
lipoteichoic acid
|
scispacy | 1 | |
| 약물 | LTA
→ lipoteichoic acid
|
C0065067
lipoteichoic acid
|
scispacy | 1 | |
| 약물 | lipopolysaccharide
|
C0023810
Lipopolysaccharides
|
scispacy | 1 | |
| 약물 | LPS
→ lipopolysaccharide
|
C0023810
Lipopolysaccharides
|
scispacy | 1 | |
| 질환 | post-burn
|
scispacy | 1 | ||
| 질환 | fibroproliferative disorders
|
scispacy | 1 | ||
| 질환 | Burn tissue samples' stimulation
|
scispacy | 1 | ||
| 질환 | hypertrophic scarring
|
C0162810
Cicatrix, Hypertrophic
|
scispacy | 1 | |
| 질환 | inflammation
|
C0021368
Inflammation
|
scispacy | 1 | |
| 기타 | toll-like receptor
|
scispacy | 1 | ||
| 기타 | TLR2
|
scispacy | 1 | ||
| 기타 | TLR4
|
scispacy | 1 | ||
| 기타 | decorin
|
scispacy | 1 | ||
| 기타 | biglycan
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 |
MeSH Terms
Cicatrix, Hypertrophic; Fibroblasts; Humans; Skin Diseases; Toll-Like Receptor 4; Wound Healing
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- What is the potential role of the nonopioid suzetrigine in pain management?
- Ex Vivo and In Vivo Histological Evaluation of a 3-μm Wavelength, 40-μm Spot Size Fractional Laser System for Dermatology.
- Correspondence on "Lymphatic pathway remodeling in the supraumbilical region after abdominoplasty: A prospective cohort study".
- Sculpting Success-The TULUANHA: Modified TULUA Lipo-Abdominoplasty in Post-Bariatric Body Contouring.